Cargando…
Early vs. Delayed Initiation of Treatment With P2Y(12) Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
AIMS: Whether early or delayed dual antiplatelet therapy initiation is better in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is unclear. We assessed the evidence for comparing the efficacy and safety of early vs. delayed P2Y(12) inhibitor initiation in NSTE-ACS. METHODS...
Autores principales: | Vicent, Lourdes, Diaz-Arocutipa, Carlos, Tarantini, Giuseppe, Mojoli, Marco, Hernandez, Adrian V., Bueno, Héctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095971/ https://www.ncbi.nlm.nih.gov/pubmed/35571182 http://dx.doi.org/10.3389/fcvm.2022.862452 |
Ejemplares similares
-
Association Between Previous or Active Cancer and Clinical Outcomes in TAVR Patients: A Systematic Review and Meta-Analysis of 255,840 Patients
por: Diaz-Arocutipa, Carlos, et al.
Publicado: (2021) -
ST-segment elevation in patients with COVID-19: a systematic review
por: Diaz-Arocutipa, Carlos, et al.
Publicado: (2021) -
Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023) -
Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022) -
Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction
por: Zhang, Xiaolin, et al.
Publicado: (2021)